Abstract
Tobacco smoking is the first cause of preventable death in modern countries. Nicotine replacement therapy or sustained release bupropion helps smoking cessation, but relapse rates are still very high. Nicotine, like other drugs of abuse, activates the dopamine mesolimbic system, which originates in the ventral tegmental area and projects notably to the nucleus accumbens. Situations or environmental stimuli previously associated with cigarette smoking, for example, smell of cigarette smoke, can elicit craving in abstinent smokers and promote relapse. Reducing the effects of nicotine-associated cues might therefore have potential therapeutic utility for smoking cessation. Such an approach has been validated for cocaine in animals, by using the dopamine D3 receptor-selective partial agonist BP 897, which inhibits cocaine cue-induced drug-seeking behavior. Here we show that rats repeatedly injected with nicotine in a particular environment develop nicotine-conditioned locomotor responses, accompanied by an increase in D3 receptor expression in the nucleus accumbens. This conditioned behavior was inhibited by BP 897 or a selective D3 receptor antagonist, suggesting that antagonizing dopamine selectively at the D3 receptor disrupts nicotine-conditioned effects and might represent a novel therapeutic approach for smoking cessation.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Pilla M, Perachon S, Sautel F, Garrido F, Mann A, Wermuth CG et al. Selective inhibition of cocaine-seeking behaviour by a partial dopamine D3 receptor agonist. Nature 1999; 400: 371–375.
Goldberg SR, Morse WH, Goldberg DM . Behavior maintained under a second-order schedule by intramuscular injection of morphine or cocaine in rhesus monkeys. J Pharmacol Exp Ther 1976; 199: 278–286.
Arroyo M, Markou A, Robbins TW, Everitt BJ . Acquisition, maintenance and reinstatement of intravenous cocaine self-administration under a second-order schedule of reinforcement in rats: effects of conditioned cues and continuous access to cocaine. Psychopharmacology 1999; 140: 331–344.
Beardsley PM, Sokoloff P, Balster RL, Schwartz J-C . The D3R partial agonist BP 897 attenuates the discriminative stimulus effects of cocaine and amphetamine and is not self-administered. Behav Pharmacol 2001; 11: 1–11.
Pert A, Post R, Weiss SR . Conditioning as a critical determinant of sensitization induced by psychomotor stimulants. NIDA Res Monogr 1990; 97: 208–241.
Walter S, Kuschinsky K . Conditioning of nicotine effects on motility and behaviour in rats. Naunyn-Schmiedeberg Arch Pharmacol 1989; 339: 208–213.
Robinson TE, Berridge KC . Incentive-sensitization and addiction. Addiction 2001; 96: 103–114.
Post RM, Weiss SR, Pert A . The role of context and conditioning in behavioral sensitization to cocaine. Psychopharmacol Bull 1987; 23: 425–429.
Kalivas PW, Stewart J . Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity. Brain Res Rev 1991; 16: 223–244.
Birrell CE, Balfour DJ . The influence of nicotine pretreatment on mesoaccumbens dopamine overflow and locomotor responses to D-amphetamine. Psychopharmacology (Berl) 1998; 140: 142–149.
Cadoni C, Di Chiara G . Differential changes in accumbens shell and core dopamine in behavioral sensitization to nicotine. Eur J Pharmacol 2000; 387: R23–R25.
Imperato A, Mulas A, Di Chiara G . Nicotine preferentially stimulates dopamine release in the limbic system of freely moving rats. Eur J Pharmacol 1986; 132: 337–338.
Lévesque D, Martres M-P, Diaz J, Griffon N, Lammers CH, Sokoloff P et al. A paradoxical regulation of the dopamine D3 receptor expression suggests the involvement of an anterograde factor from dopamine neurons. Proc Natl Acad Sci USA 1995; 92: 1719–1723.
Pontieri FE, Tanda G, Orzi F, Di Chiara G . Effects of nicotine on the nucleus accumbens and similarity to those of addictive drugs. Nature 1996; 382: 255–257.
Burris KD, Filtz TM, Chumpradit S, Kung MP, Foulon C, Hensler JG et al. Characterization of 125I R trans 7-OH-PIPAT binding to dopamine D3 receptors in rat olfactory tubercule. J Pharmacol Exp Ther 1994; 268: 935–942.
Staley JK, Mash DC . Adaptive increase in D3 dopamine receptors in the brain reward circuits of human cocaine fatalities. J Neurosci 1996; 16: 6100–6106.
Bordet R, Ridray S, Carboni S, Diaz J, Sokoloff P, Schwartz J-C . Induction of dopamine D3 receptor as a mechanism of behavioral sensitization to levodopa. Proc Natl Acad Sci USA 1997; 94: 3363–3367.
Pilla M, Hutcheson DM, Adib-Samil P, Potton E, Everitt BJ . Seeking responses for cocaine, heroin and natural reinforcers are differentially modulated by dopamine D3 receptors. Soc Neurosci Abst 2001; 27: Program No 647.16.
Reavill C, Taylor SG, Wood MD, Ashmeade T, Austin NE, Avenell KY et al. Pharmacological actions of a novel, high-affinity, and selective human dopamine D(3) receptor antagonist, SB-277011-A. J Pharmacol Exp Ther 2000; 294: 1154–1165.
Di Ciano P, Underwood R, Hagan JJ, Everitt BJ . Attenuation of cue-controlled drug-seeking by a selective D3 dopamine receptor antagonist. Behav Pharmacol 2001; 12 (Suppl 1): S29.
Mirenowicz J, Schultz W . Preferential activation of midbrain dopamine neurons by appetitive rather than aversive stimuli. Nature 1996; 379: 449–451.
Ridray S, Griffon N, Souil E, Mignon V, Carboni S, Diaz J et al. Coexpression of dopamine D1 and D3 receptors in rat ventral striatum: opposite and synergistic functional interactions. Eur J Neurosci 1998; 10: 1676–1686.
Bevins RA, Besheer J, Pickett KS . Nicotine-conditioned locomotor activity in rats: dopaminergic and GABAergic influences on conditioned expression. Pharmacol Biochem Behav 2001; 68: 135–145.
Karlsson P, Smith L, Farde L, Harnryd C, Sedvall G, Wiesel FA . Lack of apparent antipsychotic effect of the D1-dopamine receptor antagonist SCH 39166 in acutely ill schizophrenic patients. Psychopharmacology (Berl) 1995; 121: 309–316.
Eke T, Talbot JF, Lawden MC . Severe persistent visual field constriction associated with vigabatrin. B Med J 1997; 314: 180–181.
Shiffman S, Shumaker SA, Abrams DB, Cohen S, Garvey A, Grunberg NE et al. Models of smoking relapse. Health Psychol 1986; 5: 13–27.
Le Foll B, Schwartz J-C, Sokoloff P . Dopamine D3 receptor agents as potential new medications for drug addiction. Eur Psychiatry 2000; 15: 140–146.
Acknowledgements
This work was supported by grants to PS from the European Commission (FP5 Programme QLG4-CT-1999-00075) and to BLF from the Mission Interministérielle de Lutte contre la Dépendance et la Toxicomanie (RBM 01-02).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Le Foll, B., Schwartz, JC. & Sokoloff, P. Disruption of nicotine conditioning by dopamine D3 receptor ligands. Mol Psychiatry 8, 225–230 (2003). https://doi.org/10.1038/sj.mp.4001202
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.mp.4001202
This article is cited by
-
Exploring regulation and function of dopamine D3 receptors in alcohol use disorder. A PET [11C]-(+)-PHNO study
Neuropsychopharmacology (2021)
-
Brain Renin–Angiotensin System Blockade Attenuates Methamphetamine-Induced Hyperlocomotion and Neurotoxicity
Neurotherapeutics (2018)
-
Dopamine D3 Receptors in the Basolateral Amygdala and the Lateral Habenula Modulate Cue-Induced Reinstatement of Nicotine Seeking
Neuropsychopharmacology (2014)
-
Elevation of Dopamine Induced by Cigarette Smoking: Novel Insights from a [11C]-(+)-PHNO PET Study in Humans
Neuropsychopharmacology (2014)
-
Rationale in support of the use of selective dopamine D3 receptor antagonists for the pharmacotherapeutic management of substance use disorders
Naunyn-Schmiedeberg's Archives of Pharmacology (2013)